Ireland
--:--IST
Recruiting Not applicable

Single-centre Descriptive Study of Taste in Frontotemporal Lobar Degeneration Through the Analysis of Taste Evoked Potentials

NCT07110207 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2025-08-18
Last updated
2025-08-24

Condition(s) studied

Frontotemporal Lobar Degeneration (FTLD)

Investigational drug(s) / intervention(s)

Blood test →Interrogation of the subjectCognitive assessmentNutritional assessmentTaste testsSucrose taste detection test

Blood test: Metabolic measurements and measurements of hormones related to food intake

Interrogation of the subject: Collection of socio-demographic data, medical and family history, medication

Cognitive assessment: MMSE and MoCA cognitive tests

Nutritional assessment: Anthropometric data (weight, height, BMI, waist circumference, hip circumference, android/gynoid ratio, triceps skinfold thickness, brachial circumference), bioelectrical impedance analysis (body fat percentage, lean body mass, body water percentage and bone mass in kg)

Taste tests: Recording of PEGs in response to a sucrose solution (prepared beforehand)

Sucrose taste detection test: Triangular test

Study summary

The FRONTAL-PEG study focuses on taste perception in frontotemporal lobar degeneration (FTLD). This neurodegenerative disease, characterised by progressive loss of nerve cells, is the second leading cause of dementia after Alzheimer's disease.

Patients with FTLD often experience olfactory disorders (= sense of smell) and eating disorders: increased appetite, increased food intake and excessive consumption of sugary foods and snacking. This often leads to excessive weight gain. These eating disorders are still poorly understood at present.

In this context, we hypothesise that an alteration in the gustatory pathway - i.e. the way in which the brain perceives taste - could contribute to the eating disorders frequently observed in frontotemporal dementia (FTD), particularly in the marked attraction to sweet foods. We therefore wish to objectively evaluate the taste response to a sweet solution (sucrose) in patients with FTLD, using taste evoked potentials (TEPs). Taste evoked potentials are a reliable and reproducible technique for assessing brain activity in response to taste stimulation. One of their advantages is that they are non-invasive.

This study will document, for the first time in this disease, the characteristics of cortical (brain) processing of taste information.

The FRONTAL-PEG study is an interventional, regional, single-centre study conducted at the Dijon University Hospital, in collaboration with the CMRR (Memory, Resources and Research Centre) and the CSGA (Centre for Taste and Food Sciences).

All investigations are carried out at the CSGA (building adjacent to the Dijon University Hospital), with the exception of blood tests, which are carried out at the Dijon University Hospital.

The total duration of participation in the study is one morning. No follow-up is planned at the end of the study.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Person who has given their free and informed consent * Person of legal age * Fasting \> 2 hours before PEG measurement * Body Mass Index (BMI) \< 30 kg/m² (according to medical record data) * DLFT: diagnostic criteria for established or probable DLFT Exclusion Criteria: * Persons not affiliated with or not covered by a social security scheme * Persons subject to legal protection measures (guardianship, trusteeship) * Persons subject to judicial protection measures * Pregnant women, women in labour or breastfeeding women * MMSE score \< 15 and/or MoCA score \< 10 * Known COVID-19 infection within 6 months prior to inclusion * Active smokers (\> 4 cigarettes per day on a regular basis) * Subject with a pacemaker (contraindication for bioelectrical impedance analysis) * Subject with diabetes (type 1 or type 2) * Taking medication (during the study) that interferes with taste

Primary outcome measure(s)

  • Average latency of taste evoked potentials — After a fasting period of at least two hours

Trial sites (1)

FacilityCityRegionStatus
CHU Dijon Bourgogne Dijon France Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07110207 on ClinicalTrials.gov ↗ ← All trials in France